Prevention of Venous Thromboembolic Events After Elective Orthopaedic Surgery in Patients Treated With PRADAXA

CompletedOBSERVATIONAL
Enrollment

1,676

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Venous Thromboembolism
Trial Locations (53)

Unknown

Boehringer Ingelheim Investigational Site 30, Angers

Boehringer Ingelheim Investigational Site 41, Arles

Boehringer Ingelheim Investigational Site 40, Beauvais

Boehringer Ingelheim Investigational Site 2, Berck

Boehringer Ingelheim Investigational Site 25, Bordeaux

Boehringer Ingelheim Investigational Site 45, Boulogne-sur-Mer

Boehringer Ingelheim Investigational Site 13, Bruay-la-Buissière

Boehringer Ingelheim Investigational Site 42, Cahors

Boehringer Ingelheim Investigational Site 50, Castelnau-le-Lez

Boehringer Ingelheim Investigational Site 36, Chantilly

Boehringer Ingelheim Investigational Site 35, Châteaubernard

Boehringer Ingelheim Investigational Site 10, Châteaubriant

Boehringer Ingelheim Investigational Site 9, Clinique Des Maussins-Paris

Boehringer Ingelheim Investigational Site 44, Dole

Boehringer Ingelheim Investigational Site 3, Dracy-le-Fort

Boehringer Ingelheim Investigational Site 46, Haguenau

Boehringer Ingelheim Investigational Site 33, Illkirch-Graffenstaden

Boehringer Ingelheim Investigational Site 23, La Roche-sur-Yon

Boehringer Ingelheim Investigational Site 22, Lannion

Boehringer Ingelheim Investigational Site 27, Le Blanc Menil

Boehringer Ingelheim Investigational Site 31, Le Port-Marly

Boehringer Ingelheim Investigational Site 21, Libourne

Boehringer Ingelheim Investigational Site 5, Lille

Boehringer Ingelheim Investigational Site 19, Lyon

Boehringer Ingelheim Investigational Site 47, Marcq En Bareuil

Boehringer Ingelheim Investigational Site 12, Mâcon

Boehringer Ingelheim Investigational Site 28, Mérignac

Boehringer Ingelheim Investigational Site 26, Morlaix

Boehringer Ingelheim Investigational Site 48, Nancy

Boehringer Ingelheim Investigational Site 7, Nancy

Boehringer Ingelheim Investigational Site 8, Nice

Boehringer Ingelheim Investigational Site 11, Paris

Boehringer Ingelheim Investigational Site 17, Paris

Boehringer Ingelheim Investigational Site 6, Paris

Boehringer Ingelheim Investigational Site 24, Perpignan

Boehringer Ingelheim Investigational Site 49, Ploemeur

Boehringer Ingelheim Investigational Site 14, Poissy

Boehringer Ingelheim Investigational Site 39, Pontarlier

Boehringer Ingelheim Investigational Site 43, Pringy

Boehringer Ingelheim Investigational Site 15, Reims

Boehringer Ingelheim Investigational Site 20, Rennes

Boehringer Ingelheim Investigational Site 53, Saint Colombe Les Viennes

Boehringer Ingelheim Investigational Site 52, Saint-Georges-de-Didonne

Boehringer Ingelheim Investigational Site 4, Saint-Grégoire

Boehringer Ingelheim Investigational Site 18, Saint-Priest-en-Jarez

Boehringer Ingelheim Investigational Site 32, Saint-Priest-en-Jarez

Boehringer Ingelheim Investigational Site 51, Saint-Saulve

Boehringer Ingelheim Investigational Site 37, Saumur

Boehringer Ingelheim Investigational Site 34, Semur-en-Auxois

Boehringer Ingelheim Investigational Site 1, Strasbourg

Boehringer Ingelheim Investigational Site 38, Toulouse

Boehringer Ingelheim Investigational Site 29, Tourcoing

Boehringer Ingelheim Investigational Site 16, Villeneuve-sur-Lot

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY